Acquiring Company
Lesaffre
Acquired Company
Biorigin
Description
Lesaffre, a global player in fermentation and microorganisms, has acquired a majority stake in Biorigin, a business unit of Zilor, to strengthen and broaden its savory ingredients offering. The acquisition aims to leverage the complementary capabilities of Lesaffre and Biorigin to enable enhanced yeast derivative and savory ingredient solutions for customers worldwide.
Other recent acquisitions in Food and Beverage and Food and Beverage
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Actylis completes acquisition of Pharm-Rx to enhance its portfolio and capabilities (October 7, 2024)
- Turpaz acquires British flavor company F&E for £22 million, continuing its expansion strategy, $29M (September 3, 2024)
- Boston Scientific completes acquisition of Axonics, Inc. to expand into sacral neuromodulation (November 15, 2024)
- Flashpoint Therapeutics announces $50M Partnership with KAIMRC and Clinical Pipeline Expansion (November 14, 2024)
- SciSafe acquired and invested by 1315 Capital for expansion of biostorage solutions (November 14, 2024)
- Celltrion acquires iQone Healthcare Switzerland to strengthen European expansion (November 14, 2024)
Who to call at Lesaffre, and when
When Lesaffre changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Lesaffre raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Lesaffre, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Lesaffre. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Lesaffre makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Biorigin?
Biorigin was acquired by Lesaffre, based in Lille. The deal was reported on October 4, 2024. Lesaffre is an independent key global player in fermentation and microorganisms with a 3-billion-euro turnover. Lesaffre is privately held and operates in Biotechnology.
When did Lesaffre acquire Biorigin?
Lesaffre's acquisition of Biorigin was reported on October 4, 2024. Lesaffre, a global player in fermentation and microorganisms, has acquired a majority stake in Biorigin, a business unit of Zilor, to strengthen and broaden its savory ingredients offering. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Biorigin do?
Biorigin is a business unit of Zilor, a multinational company producing yeast derivative products. It is privately held, operating in Biotechnology, and is based in Sao Paulo.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.